Alere Sues To Compel Completion Of Abbott Merger

Abbott's confidence in the planned $5.8b deal has declined since the acquisition was announced in January following disclosures of investigations into Alere's business practices. Alere hopes the suit will prod Abbott to speed its efforts to secure regulatory approvals for the merger.

More from Business

More from Medtech Insight